Antiarrhythmic Drugs: Risks and Benefits.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31378328.
- Also identified by DOI 10.1016/j.mcna.2019.05.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The narrow therapeutic window of antiarrhythmic drugs makes their use clinically challenging. A solid understanding of the mechanisms of arrhythmias and how antiarrhythmics affect these mechanisms is only a preliminary step in their appropriate selection. Clinical factors, side-effect profiles, and proarrhythmic risks are more important than the cellular mechanisms of actions in drug selection and monitoring. This article provides a simplified approach to understanding cellular mechanisms and provides a practical approach to the selection and use of this important class of medications.
Medical subject headings
- Anti-Arrhythmia Agents
- Arrhythmias, Cardiac